Cresco Labs (CRLBF) Net Income towards Common Stockholders (2020 - 2026)

Cresco Labs (CRLBF) has 7 years of Net Income towards Common Stockholders data on file, last reported at -$13.3 million in Q1 2026.

• Quarterly Net Income towards Common Stockholders rose 8.04% year-over-year to -$13.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$132.2 million (down 79.26% YoY) and the FY2025 annual result came in at -$140.0 million, down 131.52% from the prior year.
• Net Income towards Common Stockholders grew to -$13.3 million in Q1 2026, from -$85.3 million in the prior quarter.
• In the past five years, Net Income towards Common Stockholders ranged from a high of $27.4 million in Q1 2022 to a low of -$161.3 million in Q4 2022.
• A 5-year average of -$32.0 million and a median of -$14.4 million in 2025 frame the typical range for Net Income towards Common Stockholders.
• Annual changes were most pronounced in 2024 — Net Income towards Common Stockholders jumped 115.22% — and 2025, when it slumped 1604.87%.
• Tracing CRLBF's Net Income towards Common Stockholders over 5 years: stood at -$161.3 million in 2022, then soared by 101.63% to $2.6 million in 2023, then soared by 115.22% to $5.7 million in 2024, then tumbled by 1604.87% to -$85.3 million in 2025, then jumped by 84.45% to -$13.3 million in 2026.
• The last three Net Income towards Common Stockholders figures came in at -$13.3 million (Q1 2026), -$85.3 million (Q4 2025), and -$17.3 million (Q3 2025), per Business Quant data.